21 completed. 21 Phase 2, 4 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 21 | Completed 21 |
| Phase 1 | 4 | Completed 4 |
| Phase 3 | 1 | Completed 1 |
Follow Major Depression: new trials by email Literature Review of Major Depression trials Research Report on Major Depression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Technology Enhanced Family Treatment Family-Focused Treatment with MCC App - Mood Disorders, Bipolar Disorder | Phase 1 / Phase 2 | Completed | University of California, Los Angeles | 65 | 2018-11-15 | 2024-05-28 |
| A Study to Evaluate SAGE-217 in Participants With Moderate to Severe Major Depressive Disorder SAGE-217, Placebo - Major Depression | Phase 2 | Completed | Biogen | 102 | 2016-12-07 | 2023-11-28 |
| Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder AV 101 (4-Chlorokynurenine), Placebo Comparator - Major Depression | Phase 2 | Completed | National Institute of Mental Health (NIMH) | 22 | 2015-10-14 | 2022-04-11 |
| Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression Ayahuasca, placebo - Major Depression | Phase 1 / Phase 2 | Completed | Universidade Federal do Rio Grande do Norte | 35 | 2014-02-01 | 2025-04-06 |
| Deep Brain Stimulation of the Superolateral Branch of the Medial Forebrain Bundle (slMFB) for the Treatment of Refractory Major Depression Deep Brain Stimulation with Activa PC Multi-program Neurostimulator - Major Depression | Phase 2 | Completed | University Hospital, Bonn | 16 | 2013-07-01 | 2018-08-07 |
| Trial of Transcranial Direct Current Stimulation (tDCS) for Depression tDCS (Eldith DC-Stimulator (CE certified)) - Major Depression | Phase 2 | Completed | The University of New South Wales | 3 | 2010-12-01 | 2015-09-17 |
| Open Pilot Trial of TES for Depression tDCS (Eldith DC-Stimulator (CE certified)) - Major Depression | Phase 2 | Completed | The University of New South Wales | 7 | 2010-09-01 | 2015-12-02 |
| Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric Conditions Escitalopram, Placebo - TBI, Major Depression | Phase 2 | Completed | Johns Hopkins University | 16 | 2010-04-01 | 2016-10-24 |
| Long-term Bilateral Theta Burst Stimulation for the Treatment of Major Depression Repetitive Transcranial Magnetic Stimulation (Theta Burst Stimulation, TBS) - Major Depression | Phase 2 / Phase 3 | Completed | University Hospital Tuebingen | 32 | 2010-04-01 | 2013-07-16 |
| Computerized Information-Processing Bias Retraining in Depressed Adolescents Computerized Information-Processing Bias Retraining, Attention Control Training - Major Depression | Phase 2 | Completed | Massachusetts General Hospital | 48 | 2010-03-01 | 2012-05-03 |
| A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder SSR125543, escitalopram, placebo - Major Depression | Phase 2 | Completed | Sanofi | 580 | 2010-02-01 | 2011-04-14 |
| Trial of Transcranial Direct Current Stimulation (tDCS) Using Alternative Electrode Montages tDCS (Eldith DC-Stimulator (CE certified)) - Major Depression | Phase 2 | Completed | The University of New South Wales | 29 | 2009-11-01 | 2016-05-24 |
| N-methylglycine (Sarcosine) Treatment for Depression citalopram, sarcosine - Major Depressive Disorder, Depression | Phase 2 | Completed | China Medical University Hospital | 40 | 2009-04-01 | 2011-07-12 |
| Evaluation of the H-Coil Transcranial Magnetic Stimulation(TMS) Device- Augmentation for Drug Resistant Depression TMS - Major Depression | Phase 2 | Completed | BeerYaakov Mental Health Center | 40 | 2008-01-01 | 2009-10-06 |
| Cimicoxib for the Treatment of Major Depression (SECIM) Cimicoxib, Placebo - Major Depression | Phase 2 | Completed | Affectis Pharmaceuticals AG | 169 | 2007-10-01 | 2013-11-13 |
| Evaluation of the Deep TMS H-Coil in the Treatment of Major Depression- Augmentation of Antidepressant Medication Transcranial Magnetic Stimulation (TMS) - Major Depression | Phase 1 / Phase 2 | Completed | Hadassah Medical Organization | 57 | 2007-04-01 | 2015-03-20 |
| Functional Neuroimaging in Depression Oral administration of escitalopram during 8 weeks - Major Depression | Phase 2 | Completed | University Hospital, Ghent | 40 | 2007-03-01 | 2010-08-31 |
| Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation Eicosapentaenoic acid (omega-3 fatty acid), Placebo - Schizophrenia, Schizoaffective Disorder | Phase 2 | Completed | University of Pittsburgh | 57 | 2005-09-01 | 2017-04-10 |
| Lexapro and Pramipexole and to Treat Major Depression Pramipexole, Escitalopram - Major Depression | Phase 2 | Completed | National Institute of Mental Health (NIMH) | 39 | 2004-06-01 | 2013-01-28 |
| Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group fluoxetine or desipramine - Major Depressive Disorder, Major Depression | Phase 2 | Completed | National Institute of General Medical Sciences (NIGMS) | 700 | 1999-11-01 | 2008-10-10 |
Showing 20 of 21. Sign in to see all of them.
Depressive Disorder, Major (21) · Depression (11) · Bipolar Disorder (2) · Dysthymic Disorder (2) · Mood Disorders (2) · Anxiety Disorders (1) · Behavior (1) · Coronary Artery Disease (1) · Depressive Disorder (1) · Psychotic Disorders (1) · Schizophrenia (1)
Mental Disorders (21) · Depressive Disorder (20) · Mood Disorders (19) · Behavioral Symptoms (11) · Behavior (10) · Bipolar and Related Disorders (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Heart Diseases (1) · Myocardial Ischemia (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1) · Vascular Diseases (1)
Escitalopram (3) · Transcranial Direct Current Stimulation (3) · Fluoxetine (2) · Transcranial Magnetic Stimulation (2) · 4-chlorokynurenine (1) · Citalopram (1) · Deep Brain Stimulation (1) · Desipramine (1) · Eicosapentaenoic Acid (1) · Fatty Acids, Omega-3 (1) · Imipramine (1) · Pramipexole (1) · SSR125543 (1) · Sarcosine (1) · Soybean Oil (1)
The University of New South Wales (3) · National Institute of Mental Health (NIMH) (2) · Affectis Pharmaceuticals AG (1) · BeerYaakov Mental Health Center (1) · Biogen (1) · China Medical University Hospital (1) · Hadassah Medical Organization (1) · Johns Hopkins University (1) · Massachusetts General Hospital (1) · National Institute of General Medical Sciences (NIGMS) (1) · New York State Psychiatric Institute (1) · Sanofi (1) · Universidade Federal do Rio Grande do Norte (1) · University Hospital Tuebingen (1) · University Hospital, Bonn (1)
United States (9) · Germany (4) · Australia (3) · Belgium (2) · Israel (2) · Austria (1) · Brazil (1) · Canada (1) · Chile (1) · Czechia (1) · Estonia (1) · Finland (1) · France (1) · Netherlands (1) · Russia (1)
Carlos A Zarate, M.D. (2) · Armen Arevian, MD (1) · Chieh-Liang Huang, MD (1) · Colleen Loo, MBBS (1) · Colleen Loo, MBBS, FRANZCP, MD (1) · David J Miklowitz, PhD (1) · Draulio B de Araujo, Ph.D (1) · Hsien-Yuan Lane, M.D., Ph.D (1) · Jamie A Micco, PhD (1) · Jeffrey K Yao, Ph.D., FACB (1) · Jonathan W. Stewart, MD. (1) · Julio Licinio, MD (1) · Kurt Audenaert, MD, PhD (1)
PMID 15365580, PMID 18061147, PMID 19414708, PMID 23562005, PMID 25220861, PMID 29903051, PMID 30253883, PMID 31231276, PMID 31798447, PMID 32236521, PMID 33128939, PMID 33360365, PMID 34510411, PMID 34817851, PMID 35378149, PMID 38094620, PMID 40109484, PMID 40494497, PMID 41257792, PMID 41743330, PMID 42171126, PMID 42498781, PMID 42521762
2009 (1), R34MH117200 (1)